While the coronavirus disease (COVID-19) accounts for the current global pandemic, the emergence of other unknown pathogens, named “Disease X,” remains a serious concern in the future. Emerging or re-emerging pathogens continue to pose significant challenges to global public health. In response, the scientific community has been urged to create advanced platform technologies to meet the ever-increasing needs presented by these devastating diseases with pandemic potential. This review aims to bring new insights to allow for the application of advanced nanomaterials in future diagnostics, vaccines, and antiviral therapies, thereby addressing the challenges associated with the current preparedness strategies in clinical settings against viruses. The application of nanomaterials has advanced medicine and provided cutting-edge solutions for unmet needs. Herein, an overview of the currently available nanotechnologies is presented, highlighting the significant features that enable them to control infectious diseases, and identifying the challenges that remain to be addressed for the commercial production of nano-based products is presented. Finally, to conclude, the development of a nanomaterial-based system using a “One Health” approach is suggested. This strategy would require a transdisciplinary collaboration and communication between all stakeholders throughout the entire process spanning across research and development, as well as the preclinical, clinical, and manufacturing phases.
Bibliographical noteFunding Information:
E.K., E.‐K.L., G.P., and C.P. contributed equally to this work. E.K. acknowledges support from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2020R1F1A1066247). E.‐K.L. acknowledges support from the Basic Science Research Program of the NRF funded by MSIT (No. NRF2018R1C1B6005424), the Center for BioNano Health Guard funded by the Ministry of Science and ICT (MSIT) as a Global Frontier Project (H‐GUARD 2014M3A6B2060507), and the KRIBB Research Initiative Program. D.S. acknowledges support from the Korea Mouse Phenotyping Project (No. NRF‐2019M3A9D5A01102797) of the Ministry of Science, ICT and Future Planning through the National Research Foundation. S.H. acknowledges support from the Bio & Medical Technology Development Programs of the NRF funded by MSIT (Nos. NRF‐2018M3A9H4056340 and NRF‐2018M3A9E2022819) and the Nano Material Technology Development Program through the NRF funded by the Ministry of Education, Science and Technology (No. 2017M3A7B4041798).
© 2021 Wiley-VCH GmbH
All Science Journal Classification (ASJC) codes
- Materials Science(all)
- Mechanics of Materials
- Mechanical Engineering